These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 10649998)

  • 1. A tale of two futures: HIV and antiretroviral therapy in San Francisco.
    Blower SM; Gershengorn HB; Grant RM
    Science; 2000 Jan; 287(5453):650-4. PubMed ID: 10649998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversibility of HIV drug resistance.
    Davenport MP
    Science; 2000 May; 288(5470):1299. PubMed ID: 10847833
    [No Abstract]   [Full Text] [Related]  

  • 3. Evolutionary dynamics of complex networks of HIV drug-resistant strains: the case of San Francisco.
    Smith RJ; Okano JT; Kahn JS; Bodine EN; Blower S
    Science; 2010 Feb; 327(5966):697-701. PubMed ID: 20075214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination antiretroviral therapy and recent declines in AIDS incidence and mortality.
    Vittinghoff E; Scheer S; O'Malley P; Colfax G; Holmberg SD; Buchbinder SP
    J Infect Dis; 1999 Mar; 179(3):717-20. PubMed ID: 9952385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in the San Francisco Human Immunodeficiency Virus Epidemic in the "Getting to Zero" Era.
    Scheer S; Hsu L; Schwarcz S; Pipkin S; Havlir D; Buchbinder S; Hessol NA
    Clin Infect Dis; 2018 Mar; 66(7):1027-1034. PubMed ID: 29099913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Projections of AIDS morbidity and mortality in San Francisco.
    Lemp GF; Payne SF; Rutherford GW; Hessol NA; Winkelstein W; Wiley JA; Moss AR; Chaisson RE; Chen RT; Feigal DW
    JAMA; 1990 Mar; 263(11):1497-501. PubMed ID: 2407871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic vaccines, risk behavior change, and the probability of eradicating HIV in San Francisco.
    Blower SM; McLean AR
    Science; 1994 Sep; 265(5177):1451-4. PubMed ID: 8073289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral therapy in HIV/AIDS: update from San Francisco.
    Laurence J
    AIDS Read; 2000 Mar; 10(3):133-4. PubMed ID: 10758008
    [No Abstract]   [Full Text] [Related]  

  • 9. HIV, transmitted drug resistance, and the paradox of preexposure prophylaxis.
    Supervie V; García-Lerma JG; Heneine W; Blower S
    Proc Natl Acad Sci U S A; 2010 Jul; 107(27):12381-6. PubMed ID: 20616092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost-effectiveness of oral HIV pre-exposure prophylaxis and early antiretroviral therapy in the presence of drug resistance among men who have sex with men in San Francisco.
    Shen M; Xiao Y; Rong L; Meyers LA; Bellan SE
    BMC Med; 2018 Apr; 16(1):58. PubMed ID: 29688862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AIDS epidemic in San Francisco among men who report sex with men: successes and challenges of HIV prevention.
    Katz MH
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997; 14 Suppl 2():S38-46. PubMed ID: 9070513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in causes of death among persons with AIDS: San Francisco, California, 1996-2011.
    Schwarcz SK; Vu A; Hsu LC; Hessol NA
    AIDS Patient Care STDS; 2014 Oct; 28(10):517-23. PubMed ID: 25275657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of expanded antiretroviral treatment strategies on the HIV epidemic among men who have sex with men in San Francisco.
    Charlebois ED; Das M; Porco TC; Havlir DV
    Clin Infect Dis; 2011 Apr; 52(8):1046-9. PubMed ID: 21460322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998.
    Louie JK; Hsu LC; Osmond DH; Katz MH; Schwarcz SK
    J Infect Dis; 2002 Oct; 186(7):1023-7. PubMed ID: 12232845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Modeling Approach for Estimating Patterns of Migration into and out of San Francisco by HIV Status and Race among Men Who Have Sex with Men.
    Hughes AJ; Chen YH; Scheer S; Raymond HF
    J Urban Health; 2017 Jun; 94(3):350-363. PubMed ID: 28337575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of protease inhibitors and other antiretroviral treatments on acquired immunodeficiency syndrome survival in San Francisco, California, 1987-1996.
    Schwarcz SK; Hsu LC; Vittinghoff E; Katz MH
    Am J Epidemiol; 2000 Jul; 152(2):178-85. PubMed ID: 10909955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Could widespread use of combination antiretroviral therapy eradicate HIV epidemics?
    Velasco-Hernandez JX; Gershengorn HB; Blower SM
    Lancet Infect Dis; 2002 Aug; 2(8):487-93. PubMed ID: 12150848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Report from San Francisco. An excerpt of the 11th Retrovirus Conference 2004].
    Oette M
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():86-7. PubMed ID: 15373063
    [No Abstract]   [Full Text] [Related]  

  • 19. Gender differences in causes of death among persons with HIV/AIDS in San Francisco, California, 1996-2013.
    Hessol NA; Schwarcz SK; Hsu LC; Shumway M; Machtinger EL
    Int J STD AIDS; 2018 Feb; 29(2):135-146. PubMed ID: 28728525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling and analysis of the San Francisco City Clinic Cohort (SFCCC) HIV-epidemic including treatment.
    Rapatski B; Tolosa J
    Math Biosci Eng; 2014 Jun; 11(3):599-619. PubMed ID: 24506553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.